FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2517381625> ?p ?o ?g. }

• W2517381625 endingPage "1571" @default.
• W2517381625 startingPage "1563" @default.
• W2517381625 abstract "To assess the association of the programmed cell death ligand 1 (PD‐L1) with cisplatin‐based neo‐adjuvant chemotherapy (NAC) response, we investigated the level of PD‐L1 and found increased PD‐L1 expression in chemo‐resistant tumors compared with chemo‐sensitive tumors according to RNA‐Seq analysis. In a cohort of 92 patients with NAC , the positive staining of PD ‐ L 1 was correlated with TNM stage, lower sensitive‐response rates and shorter overall survival rates. In another 30 paired tumor specimens pre‐ and post‐chemotherapy, the patients with high PD ‐ L 1 expression post‐chemotherapy had a worse outcome and higher stable disease rate. CD 8 + tumor‐infiltrating lymphocytes were found to be related to chemosensitive response and better prognosis and negative PD ‐ L 1 expression. Furthermore, in two patient‐derived xenograft models and cell lines A 549 and PC ‐9, cisplatin upregulated PD ‐ L 1 expression, and the enhancement of PD ‐ L 1 in cancer cell lines was in a drug dose‐dependent manner. Moreover, the depletion of PD ‐ L 1 significantly reduced cisplatin resistance. When phosphatidylinositol 3‐kinase/protein kinase B signaling was inhibited by corresponding inhibitors, PD ‐ L 1 expression was downregulated and apoptosis was upregulated in the cisplatin‐treated cancer cells. These results suggest that the upregulation of PD ‐ L 1 promotes a resistance response in lung cancer cells that might be through activation of the phosphatidylinositol 3‐kinase/protein kinase B pathway and suppression of tumor‐infiltrating lymphocytes. The high expression of PD ‐ L 1 after NAC could be an indication of therapeutic resistance and poor prognosis in patients with non‐small‐cell lung cancer." @default.
• W2517381625 created "2016-09-16" @default.
• W2517381625 creator A5014535640 @default.
• W2517381625 creator A5016679728 @default.
• W2517381625 creator A5025681399 @default.
• W2517381625 creator A5033965192 @default.
• W2517381625 creator A5046708261 @default.
• W2517381625 creator A5058333204 @default.
• W2517381625 creator A5059509650 @default.
• W2517381625 creator A5070432677 @default.
• W2517381625 creator A5073663977 @default.
• W2517381625 creator A5082143549 @default.
• W2517381625 creator A5082246965 @default.
• W2517381625 creator A5083238725 @default.
• W2517381625 creator A5085039487 @default.
• W2517381625 date "2016-11-01" @default.
• W2517381625 modified "2023-10-04" @default.
• W2517381625 title "Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy" @default.
• W2517381625 cites W1752668680 @default.
• W2517381625 cites W1966056809 @default.
• W2517381625 cites W1976269164 @default.
• W2517381625 cites W1976903466 @default.
• W2517381625 cites W1978857579 @default.
• W2517381625 cites W1984146948 @default.
• W2517381625 cites W1990779902 @default.
• W2517381625 cites W1999406978 @default.
• W2517381625 cites W2016983859 @default.
• W2517381625 cites W2041560123 @default.
• W2517381625 cites W2045975323 @default.
• W2517381625 cites W2049270621 @default.
• W2517381625 cites W2050302729 @default.
• W2517381625 cites W2062549560 @default.
• W2517381625 cites W2066948081 @default.
• W2517381625 cites W2071793654 @default.
• W2517381625 cites W2081295565 @default.
• W2517381625 cites W2089228335 @default.
• W2517381625 cites W2089735922 @default.
• W2517381625 cites W2094481139 @default.
• W2517381625 cites W2098414192 @default.
• W2517381625 cites W2110252240 @default.
• W2517381625 cites W2111225997 @default.
• W2517381625 cites W2125216206 @default.
• W2517381625 cites W2130207101 @default.
• W2517381625 cites W2140361513 @default.
• W2517381625 cites W2141037581 @default.
• W2517381625 cites W2142858201 @default.
• W2517381625 cites W2145550995 @default.
• W2517381625 cites W2159094759 @default.
• W2517381625 cites W2170552969 @default.
• W2517381625 cites W2210453860 @default.
• W2517381625 cites W2253000935 @default.
• W2517381625 cites W2258857741 @default.
• W2517381625 cites W2270816365 @default.
• W2517381625 cites W2277129094 @default.
• W2517381625 cites W2340636398 @default.
• W2517381625 cites W2486455593 @default.
• W2517381625 cites W4230195560 @default.
• W2517381625 doi "https://doi.org/10.1111/cas.13072" @default.
• W2517381625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5132280" @default.
• W2517381625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27581532" @default.
• W2517381625 hasPublicationYear "2016" @default.
• W2517381625 type Work @default.
• W2517381625 sameAs 2517381625 @default.
• W2517381625 citedByCount "134" @default.
• W2517381625 countsByYear W25173816252016 @default.
• W2517381625 countsByYear W25173816252017 @default.
• W2517381625 countsByYear W25173816252018 @default.
• W2517381625 countsByYear W25173816252019 @default.
• W2517381625 countsByYear W25173816252020 @default.
• W2517381625 countsByYear W25173816252021 @default.
• W2517381625 countsByYear W25173816252022 @default.
• W2517381625 countsByYear W25173816252023 @default.
• W2517381625 crossrefType "journal-article" @default.
• W2517381625 hasAuthorship W2517381625A5014535640 @default.
• W2517381625 hasAuthorship W2517381625A5016679728 @default.
• W2517381625 hasAuthorship W2517381625A5025681399 @default.
• W2517381625 hasAuthorship W2517381625A5033965192 @default.
• W2517381625 hasAuthorship W2517381625A5046708261 @default.
• W2517381625 hasAuthorship W2517381625A5058333204 @default.
• W2517381625 hasAuthorship W2517381625A5059509650 @default.
• W2517381625 hasAuthorship W2517381625A5070432677 @default.
• W2517381625 hasAuthorship W2517381625A5073663977 @default.
• W2517381625 hasAuthorship W2517381625A5082143549 @default.
• W2517381625 hasAuthorship W2517381625A5082246965 @default.
• W2517381625 hasAuthorship W2517381625A5083238725 @default.
• W2517381625 hasAuthorship W2517381625A5085039487 @default.
• W2517381625 hasBestOaLocation W25173816251 @default.
• W2517381625 hasConcept C104317684 @default.
• W2517381625 hasConcept C121608353 @default.
• W2517381625 hasConcept C126322002 @default.
• W2517381625 hasConcept C127561419 @default.
• W2517381625 hasConcept C143998085 @default.
• W2517381625 hasConcept C184235292 @default.
• W2517381625 hasConcept C190283241 @default.
• W2517381625 hasConcept C2776256026 @default.
• W2517381625 hasConcept C2776694085 @default.
• W2517381625 hasConcept C2778239845 @default.
• W2517381625 hasConcept C31573885 @default.

• next